Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PTCT
Stock Latest News
The Fly
PTC Therapeutics participates in a conference call with Truist
12d ago
PTCT
Premium
Company Announcements
PTC Therapeutics Completes Study on Vatiquinone for Friedreich Ataxia in Young Children
15d ago
PTCT
Premium
The Fly
PTC Therapeutics price target lowered to $71 from $76 at Morgan Stanley
18d ago
PTCT
Premium
Ratings
PTC Therapeutics: Buy Rating Affirmed Amid Temporary Weakness and Promising Pipeline
18d ago
PTCT
Premium
The Fly
JPMorgan adds PTC Therapeutics to Analyst Focus List after selloff
18d ago
PTCT
Premium
The Fly
PTC Therapeutics price target lowered to $76 from $82 at BofA
18d ago
PTCT
Premium
The Fly
PTC Therapeutics price target lowered to $73 from $79 at Wells Fargo
18d ago
PTCT
Premium
The Fly
PTC Therapeutics price target lowered to $63 from $64 at Jefferies
18d ago
PTCT
Premium
The Fly
RBC says PTC Therapeutics CRL may signal difficulty for Biohaven
18d ago
BHVN
PTCT
Premium
The Fly
PTC Therapeutics CRL ‘expected,’ focus moves to Sephience, says RBC Capital
18d ago
PTCT
Premium
Ratings
PTC Therapeutics: Buy Rating Maintained Despite Vatiquinone Setback
18d ago
PTCT
Premium
The Fly
PTC Therapeutics price target lowered to $50 from $56 at TD Cowen
18d ago
PTCT
Premium
Ratings
PTC Therapeutics: Hold Rating Amid Regulatory Setbacks and Sephience Growth Potential
18d ago
PTCT
Premium
Company Announcements
PTC Therapeutics Receives FDA Complete Response Letter
18d ago
8K
PTCT
Premium
The Fly
PTC Therapeutics receives Complete Response Letter for vatiquinone NDA
18d ago
PTCT
Premium
Company Announcements
PTC Therapeutics’ Earnings Call Highlights Sephience Success
25d ago
PTCT
Premium
The Fly
PTC Therapeutics price target lowered to $70 from $72 at Baird
29d ago
PTCT
Premium
The Fly
PTC Therapeutics price target raised to $56 from $52 at TD Cowen
29d ago
PTCT
Premium
The Fly
PTC Therapeutics price target raised to $63 from $60 at RBC Capital
29d ago
PTCT
Premium
The Fly
PTC Therapeutics price target raised to $79 from $78 at Wells Fargo
30d ago
PTCT
Premium
Company Announcements
PTC Therapeutics Reports Q2 2025 Financial Results
30d ago
PTCT
Premium
Ratings
PTC Therapeutics: Balancing Optimism and Uncertainty Amidst New Product Launches and Regulatory Decisions
30d ago
PTCT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.